Search Results - "Mlcoch, T"

Dietary patterns, cost and compliance with low-protein diet of phenylketonuria and other inherited metabolic diseases by Mlčoch, T, Puda, R, Ješina, P, Lhotáková, M, Štěrbová, Š, Doležal, T

“…Background/Objectives: Phenylketonuria (PKU) and several other inherited metabolic diseases (IMD) require a lifelong low-protein diet (LPD), otherwise they…”
Get full text

Treatment sequences in metastatic renal cell carcinoma: Efficacy results from the Czech registry (RENIS) by Finek, J., Demlova, R., Kopeckova, K., Buchler, T., Melichar, B., Prausova, J., Poprach, A., Hrnciarova, T., Mlcoch, T., Dolezal, T.

Get full text

Cost Minimization Analysis of Activated Prothrombin Complex Concentrate (Apcc) Compared To Recombinant Factor Viia (Rfviia) for Hemophilia Patients With Inhibitors by Mlcoch, T, Klimes, J, Dolezal, T

Get full text

Cost-Effectiveness Analysis of Bendamustin-Rituximab Compared to Chop-Rituximab in the Treatment of Indolent Follicular Non-Hodgkin Lymhoma in the Czech Republic by Mlcoch, T, Klimes, J, Kruntoradova, K, Mandelikova, M, Dolezal, T

Get full text

WS5.5 Economic burden of cystic fibrosis (CF): prevalence based cost of illness analysis related to the lung disease severity in Czech CF patients by Klimes, J, Dolezal, T, Vavrova, V, Turnovec, M, Skalická, V, Mlcoch, T, Jircikova, J, Drevinek, P, Macek, M

Get full text

EE295 Indirect Treatment Comparison and Cost-Minimization Analysis of Riociguat Versus Selexipag in Patients With Pulmonary Arterial Hypertension by Ornstová, E, Tužil, J, Chadimova, K, Mlcoch, T, Doležal, T

Get full text

EE440 Cost-Effectiveness Analysis of 4% Fluorouracil for the Treatment of Actinic Keratosis in the Czech Republic by Blazkova, T, Mlcoch, T, Ornstova, E, Sevec, M, Doležal, T

Get full text

HTA74 Novel Approach to Decision Making for Orphan Drugs by Decker, B, Mlcoch, T, Pustovalova, A, Doležal, T

Get full text

HTA243 Guidelines for Incorporating the Societal Perspective and Wider Societal Benefits in Health Technology Assessment by Baloghova, K., Pásztor, B., Klimes, J., Mlcoch, T., Decker, B., Kolek, M.

Get full text

EE747 Cost-Utility Analysis of 15-Valent Pneumococcal Conjugate Vaccine in the Immunization of Adults Over 65 Years of Age in the Czech Republic by Volfova, G., Mlcoch, T., Uherek, Š, Lamblová, K., Zadak, J., Vaverkova, E., Doležal, T.

Get full text

CO148 Time in Remission as an Alternative Outcome Measure for Ankylosing Spondylitis: A 4-Year Prospective Study of 1900 Users of Anti-TNF by Tužil, J, Mlcoch, T, Závada, J, Svoboda, M, Pavelka, K, Doležal, T

Get full text

PCR180 The Life with Myasthenia Gravis: Socioeconomic Impact of the Disease on Patients in the Czech Republic by Danielisova, M., Mlcoch, T., Volfova, G., Bruhova, H., Malachova, M., Horakova, M., Dolezalova, H., Chlád, R., Doležal, T.

Get full text

PCR202 Atoderma: Clinical and Economic Burden of Moderate to Severe Atopic Dermatitis in the Czech Republic by Chadimova, K., Lamblová, K., Blažková, T., Doleckova, K., Berezna, J., Tužil, J., Turková, B., Mlcoch, T., Dolezalova, H., Doležal, T.

Get full text

PCR233 Socioeconomic Impact of Muscular Dystrophies on Patients and Their Caregivers in the Czech Republic by Volfova, G., Podolska, K., Berezna, J., Chadimova, K., Dolezalova, H., Doležal, T., Reineltova, J., Brectan, R., Haberlova, J., Mlcoch, T.

Get full text

PNS133 BEYOND INTERNATIONAL PRICING INDEX MODEL IN THE UNITED STATES - IMPACT TO GLOBAL PRICING STRATEGIES & ACCESS TO INNOVATIVE MEDICINES by Svitil, P., Paris, M., Milosic, R., Mlcoch, T., Dolezal, T.

Get full text

PNS173 MEASURING DELAYS IN THE AVAILABILITY OF NEW MEDICINES WITHIN EUROPE USING A TIME-TO-PRICE INDICATOR by Milosic, R., Paris, M., Mlcoch, T., Svitil, P., Dolezal, T.

Get full text

PCV68 ECONOMIC BURDEN OF ATHEROTROMBOTIC DISEASE IN THE CZECH REPUBLIC by Hajickova, B., Mlcoch, T., Vydrova, J., Zadak, J., Dolezal, T.

Get full text

PCR234 The Burden of Migraine in Czech Republic: Patient, Payer, and Societal Perspective by Doleckova, K., Schimmerova, A., Mazalova, M., Pejřilová, D., Blažejovská, R., Volfova, G., Berezna, J., Decker, B., Mlcoch, T., Dolezalova, H., Doležal, T.

Get full text

PCR186 The Life With Cystic Fibrosis: Socioeconomic Impact of the Disease on Patients and Their Caregivers in the Czech Republic by Mlcoch, T, Velackova, B, Doleckova, K, Koznarova, B, Zabranska, S, Pilnackova, B, Decker, B, Tužil, J, Blazkova, T, Dolezalova, H, Doležal, T

Get full text

957P - Overall and progression-free survival according to MSKCC scores in 1st line sunitinib treatment of metastatic renal cell carcinoma (mRCC) by Finek, J., Poprach, A., Melichar, B., Kopecky, J., Zemanova, M., Buchler, T., Kopeckova, K., Mlcoch, T., Dolezal, T., Fiala, O.

“…Data on the efficacy and safety of all targeted therapies for metastatic renal cell carcinoma (mRCC) including sunitinib are collected in the Czech RENIS…”
Get full text